Portfolio manager comments — Q3 2025
The market performed positively during the quarter, gaining just over 3%. However, the fund lagged behind, primarily due to developments within the financial sector, where European banks continued to perform strongly. Several banks, particularly in Southern Europe, are excluded from the fund’s investment universe as a result of its screening criteria.
Among the companies that contributed most negatively to the fund’s return were Novo Nordisk and Zalando, both of which declined by around 20% following profit warnings and heightened concerns regarding growth prospects. The position in Zalando has been divested, while the holding in Novo Nordisk was increased following the share price decline. AI‑exposed companies such as Deutsche Börse, SAP, and RELX also underperformed during the period.
Holdings within the insurance sector reported weak results, and several positions within the pharmaceutical sector were weighed down by concerns over potential new drug price regulations in the U.S. The position in Hannover Re was sold following a disappointing earnings report.
The strongest positive contributors to performance were ASML, which appreciated more than 20% during the quarter, and ING, which was the fund’s top‑performing bank and its second‑best contributor overall. At the sector level, industrial companies were the primary positive drivers, with strong performance from holdings such as Legrand, Diploma, and Sandvik.
During the quarter, the fund initiated new positions in Kone, Rentokil, and Ashtead, thereby increasing its exposure to more cyclical sectors. This positioning is considered advantageous in a scenario of continued interest rate cuts.